Sotera Health Company (SHC)
NASDAQ: SHC · Real-Time Price · USD
16.37
+0.17 (1.05%)
At close: Aug 29, 2025, 4:00 PM
16.56
+0.19 (1.16%)
After-hours: Aug 29, 2025, 6:09 PM EDT
Sotera Health Company Stock Forecast
Stock Price Forecast
The 5 analysts that cover Sotera Health Company stock have a consensus rating of "Strong Buy" and an average price target of $16, which forecasts a -2.26% decrease in the stock price over the next year. The lowest target is $13 and the highest is $20.
Price Target: $16 (-2.26%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 24, 2025.
Analyst Ratings
The average analyst rating for Sotera Health Company stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 2 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $15 → $13 | Buy | Maintains | $15 → $13 | -20.59% | Jun 24, 2025 |
| Goldman Sachs | Goldman Sachs | Hold → Strong Buy Upgrades $14 → $17 | Hold → Strong Buy | Upgrades | $14 → $17 | +3.85% | May 5, 2025 |
| Piper Sandler | Piper Sandler | Hold Maintains $15 → $13 | Hold | Maintains | $15 → $13 | -20.59% | Apr 23, 2025 |
| Barclays | Barclays | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | -26.70% | Apr 10, 2025 |
| Barclays | Barclays | Buy Maintains $17 → $16 | Buy | Maintains | $17 → $16 | -2.26% | Feb 28, 2025 |
Financial Forecast
Revenue This Year
1.17B
from 1.10B
Increased by 6.23%
Revenue Next Year
1.24B
from 1.17B
Increased by 5.99%
EPS This Year
0.79
from 0.16
Increased by 406.40%
EPS Next Year
0.89
from 0.79
Increased by 12.63%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.2B | 1.3B | ||
| Avg | 1.2B | 1.2B | ||
| Low | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 10.9% | 11.4% | ||
| Avg | 6.2% | 6.0% | ||
| Low | 2.6% | 2.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 0.84 | 0.95 | ||
| Avg | 0.79 | 0.89 | ||
| Low | 0.76 | 0.85 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 435.1% | 19.5% | ||
| Avg | 406.4% | 12.6% | ||
| Low | 387.5% | 7.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.